Having multiple treatment options is the kind of advancement we’ve all been waiting for." 2. Blood tests could improve speed and accuracy of diagnosis Research this year has helped move Alzheimer’s ...

Learn about early-onset Alzheimer's through real stories of hope and breakthrough treatments that are changing lives of patients diagnosed before age ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

The Alzheimer’s Association — a Chicago-based nonprofit ... and greater opportunity to have more time. Having multiple treatment options is the kind of advancement we’ve all been waiting ...

Treatment options for early onset Alzheimer’s are primarily medications that work to lower symptoms of memory loss. Research on the condition is ongoing, and new medications are frequently being ...

The treatment is not a permanent fix for Alzheimer's dementia, Jing said ... It's important for them to know there are options out there." Offering this level of care in Lafayette is important ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact of semaglutide – marketed as Ozempic for the treatment of diabetes ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Recent studies implicate the immune system and a herpes virus as potential contributors to development of the disease.

Having multiple treatment options is the kind of advancement we’ve all been waiting for." Research this year has helped move Alzheimer’s blood tests closer to being used in physicians' offices.